Fraxinelle Pharmaceuticals Private Limited
About Fraxinelle Pharmaceuticals Private Limited
Data last updated:
Fraxinelle Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2012PTC183105. Its GSTIN is 19AACCF0656L1ZF (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.5 Lakh. It is led by directors Beauty Kumari and Mohsina Bano.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at P – 221/1 Strand Bank Road, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.15 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹38,969 (net margin 6.3%) and EBITDA of ₹43,969 (EBITDA margin 7.2%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years and 35% over five years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Fraxinelle Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP – 221/1 Strand Bank Road, Kolkata, West Bengal, India – 700001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fraxinelle Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Financials of Fraxinelle Pharmaceuticals Private Limited
FY 2022 filings availableFraxinelle Pharmaceuticals Private Limited reported revenue of ₹6.15 Lakh (down 34% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 35% over five years, including a 34% fall in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43,969 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38,969 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fraxinelle Pharmaceuticals Private Limited
Fraxinelle Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Beauty Kumari | Director | 15 Oct 2022 | 4 Years 0 Months | Current |
| Mohsina Bano | Director | 15 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Fraxinelle Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rockvet Pharmaceuticals Private Limited | ₹6.2 Lakh (FY 2024) | 146.0% | Faridabad, Haryana, India | |||
| HKS Pharmaceuticals Private Limited | ₹6.17 Lakh (FY 2020) | 160.0% | Hyderabad, Telangana, India | |||
| Fraxinelle Pharmaceuticals Private Limitedthis company | ₹6.15 Lakh (FY 2022) | ₹38,969 | 6.3% | -34.0% | Kolkata, West Bengal, India | |
| Sreetech Pharma (India) Private Limited | ₹6.12 Lakh (FY 2023) | -43.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Auditor
Fraxinelle Pharmaceuticals Private Limited is audited by MANOJ TIWARI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ TIWARI & ASSOCIATES | FY 2019 | 328173E |
Shareholding
The shareholding of Fraxinelle Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Legal cases
Fraxinelle Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed against the company by M/S Radico Remedies | Pending |
To see the full case history of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fraxinelle Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fraxinelle Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCF0656L1ZF | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fraxinelle Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fraxinelle Pharmaceuticals Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Anil Singh ceased to be Director on 17 Oct 2022.
Frequently asked questions
Fraxinelle Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 June 2012 (14+ years old) and is registered under CIN U85100WB2012PTC183105.
Fraxinelle Pharmaceuticals has 2 current directors:
- Beauty Kumari - Director
- Mohsina Bano - Director
The latest financial statements of Fraxinelle Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Fraxinelle Pharmaceuticals is 19AACCF0656L1ZF, registered in West Bengal.
The CIN (Corporate Identification Number) of Fraxinelle Pharmaceuticals is U85100WB2012PTC183105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fraxinelle Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Fraxinelle Pharmaceuticals was incorporated on 25 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Fraxinelle Pharmaceuticals by revenue are Rockvet Pharmaceuticals Private Limited, HKS Pharmaceuticals Private Limited, Sreetech Pharma (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Singh ceased to be Director on 17 Oct 2022. Dinesh Mishra ceased to be Director on 17 Oct 2022. Beauty Kumari was appointed as Director on 15 Oct 2022. Fraxinelle Pharmaceuticals has 7 board changes on record in total.
The registered office of Fraxinelle Pharmaceuticals is at P – 2211 Strand Bank Road, Kolkata, West Bengal, India – 700001.
Fraxinelle Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.